- Parties: The plaintiffs were Novartis Pharmaceuticals Canada Inc. and Novartis AG. The defendant was Apotex Inc.

- Subject Matter: This is an action before the Federal Court under the Patented Medicines (Notice of Compliance) Regulations. The matter involves a patent dispute between Novartis Pharmaceuticals Canada Inc. et al. and Apotex Inc., with ongoing motions regarding examinations for discovery, undertakings, and refusals, including a protective order granted on October 23, 2025. The case is ongoing.

- Date: The hearing was set on May 21, 2026.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.